UPB – upstream bio, inc. (US:NASDAQ)

News

Upstream Bio Appoints Allison Ambrose as General Counsel
Upstream Bio Announces Addition to Russell 2000® Index
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Upstream Bio, Inc. (NASDAQ: UPB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $75.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com